In this short interview, CEO Witty of Glaxo - British multinational pharmaceutical, biologics, vaccines and consumer healthcare company - said that while Chinese government will continue to have a tension between building its domestic industry and fomenting an open competitive market in which foreign companies participates, it does a good job of making its market fair. Most … [Read more...] about Glaxo CEO Witty on Competiveness and Innovation in China
intellectual property
Stan Abrams of China Hearsay – A Case of Pathological Bias?
I usually prefer to keep my posts on general, important issues - and not nit-pick on other bloggers. However, just as once in a while one is permitted to get drunk, I will indulge in a very short post here on Stan Abrams of China Hearsay. A few weeks ago, when China lost the WTO Appellate Body dealt China a blow in ruling that its practices on restricting exports of certain … [Read more...] about Stan Abrams of China Hearsay – A Case of Pathological Bias?
What Does SOPA (and PIPA) Tell us About “Freedom”?
As you may know, there is a heated high-profile war being waged in the U.S. now over a new bill called SOPA ("Stop Online Piracy Act" in the House) and PIPA ("Protect Intellectual Property Act" in the Senate). The bills have been temporarily put on hold, but the issues highlighted by the controversies will not go away. The purpose of the bills is to enable IP owners to … [Read more...] about What Does SOPA (and PIPA) Tell us About “Freedom”?